facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2014
vol. 101
 
Share:
Share:
abstract:
Editorial

Treatment of psoriasis vulgaris: guidelines of experts of the Polish Dermatological Society. Part II: moderate to severe psoriasis

Jacek Szepietowski
,
Zygmunt Adamski
,
Grażyna Chodorowska
,
Andrzej Kaszuba
,
Waldemar Placek
,
Lidia Rudnicka
,
Adam Reich

Przegl Dermatol 2014, 101, 455–472
Online publish date: 2014/11/25
View full text Get citation
 
PlumX metrics:
Psoriasis is a chronic inflammatory skin disease affecting about 1–3% of the general population. Recent years have seen great development in the treatment of this dermatosis, especially regarding moderate to severe psoriasis. More numerous and more widely available systemic therapies raise new challenges for all physicians treating patients with psoriasis. New questions arise about patients’ follow-up and long-term safety of such therapies. To meet the expectations of Polish dermatologists, we have prepared a second part of guidelines on the treatment of psoriasis, particularly concentrated on the therapy of severe forms of this disease. We hope that our suggestions will be valuable for physicians in their daily clinical practice. However, we would like to underline that every guideline is characterized by some vagueness, and the final decision about diagnosis and therapy should always be made individually for every patient based on the patient’s current clinical status and the most up-to-date scientific literature data.
keywords:

therapy, psoriasis, systemic drugs, phototherapy



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.